Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
得意分野
Suggested News & Insights
Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027The Nonprofit Boardroom: Current Issues, Considerations, and Emerging RisksWednesday, November 4, 2026Sidley Represents Hanmi Pharm and Green Cross Biopharma in Licensing Agreement With BioMarinOctober 30, 2026Introducing SidleyCatalyst: Built to Accelerate GrowthOctober 28, 2026Sidley Represents Bolt Biotherapeutics in the Acquisition of Prana Therapies and Concurrent US$120 Million Private Placement FinancingOctober 26, 2026Sidley Represents Savillex in Its Acquisition of Entegris’ Life Sciences Fluid Management BusinessOctober 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory